Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−24.41 USD
−6.61 M USD
18.60 K USD
816.63 K
About HeartSciences Inc.
Sector
Industry
CEO
Andrew Christopher Simpson
Website
Headquarters
Southlake
Founded
2008
FIGI
BBG0185L0044
HeartSciences, Inc. is a medical technology company, which focuses on applying innovative AI-based technology to an electrocardiogram (ECG) to expand and improve an ECG's clinical usefulness. Its objective is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It offers MyoVista, a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction. The company was founded in 2008 and is headquartered in Southlake, TX.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HSCS is 2.86 USD — it has increased by 3.62% in the past 24 hours. Watch HeartSciences Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange HeartSciences Inc. stocks are traded under the ticker HSCS.
HSCS stock has risen by 4.38% compared to the previous week, the month change is a −11.18% fall, over the last year HeartSciences Inc. has showed a −89.24% decrease.
We've gathered analysts' opinions on HeartSciences Inc. future price: according to them, HSCS price has a max estimate of 15.00 USD and a min estimate of 12.00 USD. Watch HSCS chart and read a more detailed HeartSciences Inc. stock forecast: see what analysts think of HeartSciences Inc. and suggest that you do with its stocks.
HSCS reached its all-time high on Aug 3, 2022 with the price of 600.00 USD, and its all-time low was 2.36 USD and was reached on Sep 10, 2024. View more price dynamics on HSCS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HSCS stock is 4.90% volatile and has beta coefficient of 1.13. Track HeartSciences Inc. stock price on the chart and check out the list of the most volatile stocks — is HeartSciences Inc. there?
Today HeartSciences Inc. has the market capitalization of 2.61 M, it has increased by 1.16% over the last week.
Yes, you can track HeartSciences Inc. financials in yearly and quarterly reports right on TradingView.
HeartSciences Inc. is going to release the next earnings report on Dec 12, 2024. Keep track of upcoming events with our Earnings Calendar.
HSCS earnings for the last quarter are −2.60 USD per share, whereas the estimation was −2.31 USD resulting in a −13.02% surprise. The estimated earnings for the next quarter are −2.33 USD per share. See more details about HeartSciences Inc. earnings.
HeartSciences Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
HSCS net income for the last quarter is −2.05 M USD, while the quarter before that showed −1.85 M USD of net income which accounts for −11.13% change. Track more HeartSciences Inc. financial stats to get the full picture.
No, HSCS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 27, 2024, the company has 15.00 employees. See our rating of the largest employees — is HeartSciences Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HeartSciences Inc. EBITDA is −7.00 M USD, and current EBITDA margin is −33.39 K%. See more stats in HeartSciences Inc. financial statements.
Like other stocks, HSCS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HeartSciences Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HeartSciences Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HeartSciences Inc. stock shows the sell signal. See more of HeartSciences Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.